Renal infarct in a COVID-19-positive kidney-pancreas transplant recipient

Abstract

The novel coronavirus disease 2019 (COVID-19) is associated with increased risk of thromboembolic events, but the extent and duration of this hypercoagulable state remain unknown. We describe the first case report of renal allograft infarction in a 46-year-old kidney-pancreas transplant recipient with no prior history of thromboembolism, who presented 26 days after diagnosis of COVID-19. At the time of renal infarct, he was COVID-19 symptom free and repeat test for SARS-CoV-2 was negative. This case report suggests that a hypercoagulable state may persist even after resolution of COVID-19. Further studies are required to determine thromboprophylaxis indications and duration in solid organ transplant recipients with COVID-19.

Keywords: clinical research/practice; infection and infectious agents - viral; kidney transplantation/ nephrology; thrombosis and thromboembolism.

FIGURE 1

Hypodense area of the lower pole of the transplant kidney demonstrated on computed tomography scan of abdomen pelvis (sagittal view)

FIGURE 2

Absent arterial flow in the lower pole of the transplant kidney demonstrated on renal ultrasound with Doppler [Color figure can be viewed at wileyonlinelibrary.com]